Class Information for ONS/ONCC NEW PROVIDERS Chemotherapy/Immunotherapy Certificate Course with CCND Bridge-to-Practice
Description
The ONS/ONCC® Chemotherapy and Immunotherapy Certificate of Added Qualification™ (CAQ™) program provides nurses with a comprehensive overview of chemotherapy and immunotherapy. The Bridge-to-Practice sessions review NIH specific policies and procedures related to chemotherapy/immunotherapy administration at NIH. The ONS/ONCC® Chemotherapy/Immunotherapy CAQ™ is obtained after successful completion of the course including a post-course exam. An 80% or higher must be achieved on the exam before an RN can receive the certificate. The provider card is valid for two years. The Clinical Center Nursing Department (CCND) program of care competency Chemotherapy Biotherapy requires a successful completion of this course, including the post-test examination, and of the clinical practicum prior to administering a chemotherapy or an immunotherapy. The clinical practicum will be completed on the patient care unit. This course is reserved for Clinical Center Nursing Department RNs administering chemotherapy or immunotherapy at NIH to adult patients with oncology and non-oncology diagnoses.
Contact Hours
15.25 contact hours
Special Comments
To be successful in the course, RNs need to attend all three 8-hour sessions. The location of this course may change abruptly to comply with potential safety restrictions (in person vs. online). Participants should ensure telework agreements are in place with their Nurse Manager. You will receive detailed instructions via email prior to the course start date. Participants should expect to receive a course reminder with instructions for the class day at least 1 week prior to the course. Participants will be granted online access to the ONS/ONCC Course on the first morning of class.
Target Audience
CCND RNs administering chemotherapeutic or immunotherapeutic agents to adult patients with oncology and non-oncology diagnoses
Course Objectives
1. Discuss commonly used agents, their mechanisms of action, and any unique administration issues. 2. Demonstrate knowledge of safety precautions for handling and administering chemotherapeutic and immunotherapeutic agents. 3. Discuss immediate complications of these therapies, including extravasation and hypersensitivity reactions, and the nursing interventions. 4. Identify evidence-based resources to address systemic side effects of chemotherapeutic and immunotherapeutic agents and the nursing interventions required to manage these conditions.
Pre-requisites
1. Have practiced in the CCND for at least sic (6) months. 2. Have taken the CCND Oncology Education Series: ONS online "Cancer Basics," "Oncologic Emergencies, "OES: Concepts, Trends, and Care." 3. Hold a current CCND "Safe Handling of Hazardous Drugs" competency. Special audience: CCND CRNs who have completed the Chemotherapy Biotherapy for Non-oncology Settings course and who currently hold the competency of the same name are eligible to take this course without taking the additional pre-requisites. Contact Adjoavi.Dayo@nih.gov with any questions.
Sessions Open for Registration
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
